Those pandemic puppies are growing up to be a public health concern.
Novo Nordisk to discontinue long-acting insulin Levemir next year amid incoming 65% price cut
Insulin powerhouse Novo Nordisk will discontinue its long-acting insulin Levemir in the US next year amid anticipated supply disruptions, a 65% price cut and as